Science Simplified!

                       JAI VIGNAN

All about Science - to remove misconceptions and encourage scientific temper

Communicating science to the common people

'To make  them see the world differently through the beautiful lense of  science'

Load Previous Comments
  • Dr. Krishna Kumari Challa

    Sim shows how COVID virus infects cells

  • Dr. Krishna Kumari Challa

    How Volcanic Eruptions Can Cool Earth? -- Explained!

    Climate change includes both global warming driven by human-induced emissions of greenhouse gases and the resulting large-scale shifts in weather patterns.

  • Dr. Krishna Kumari Challa

    Research on beards, wads of gum wins 2021 Ig Nobel prizes

    Beards aren't just cool and trendy—they might also be an evolutionary development to help protect a man's delicate facial bones from a punch to the face.

    That's the conclusion of a trio of scientists from the University of Utah who are among the winners of this year's Ig Nobel prizes, the Nobel Prize spoofs that honor—or maybe dishonor, depending on your point of view—strange scientific discoveries.

    The winners of the 31st annual Ig Nobels being announced Thursday included researchers who figured out how to better control cockroaches on U.S. Navy submarines; animal scientists who looked at whether it's safer to transport an airborne rhinoceros upside-down; and a team that figured out just how disgusting that discarded gum stuck to your shoe is.

    These sound like  silly studies, but as usual, there was some method to the madness. These findings have implications for a wide range of disciplines, including forensics, contagious disease control, or bioremediation of wasted chewing gum residues.

    https://www.improbable.com/2021-ceremony/winners/

    https://phys.org/news/2021-09-beards-wads-gum-ig-nobel.html?utm_sou...

  • Dr. Krishna Kumari Challa

    New programmable gene editing proteins found outside of CRISPR systems

    Within the last decade, scientists have adapted CRISPR systems from microbes into gene editing technology, a precise and programmable system for modifying DNA. Now, scientists at MIT's McGovern Institute and the Broad Institute of MIT and Harvard have discovered a new class of programmable DNA modifying systems called OMEGAs (Obligate Mobile Element Guided Activity), which may naturally be involved in shuffling small bits of DNA throughout bacterial genomes.

    These ancient DNA-cutting enzymes are guided to their targets by small pieces of RNA. While they originated in bacteria, they have now been engineered to work in human cells, suggesting they could be useful in the development of gene editing therapies, particularly as they are small (~30% the size of Cas9), making them easier to deliver to cells than bulkier enzymes. The discovery, reported in the journal Science, provides evidence that natural RNA-guided enzymes are among the most abundant proteins on earth, pointing toward a vast new area of biology that is poised to drive the next revolution in genome editing technology.

    Han Altae-Tran et al, The widespread IS200/605 transposon family encodes diverse programmable RNA-guided endonucleases, Science (2021). DOI: 10.1126/science.abj6856

    https://phys.org/news/2021-09-programmable-gene-proteins-crispr.htm...

  • Dr. Krishna Kumari Challa

    New technology designed to genetically control disease-spreading mosquitoes

    Leveraging advancements in CRISPR-based genetic engineering, researchers have created a new system that restrains populations of mosquitoes that infect millions each year with debilitating diseases.

    The new precision-guided sterile insect technique, or pgSIT, alters genes linked to male fertility—creating sterile offspring—and female flight in Aedes aegypti, the mosquito species responsible for spreading wide-ranging diseases including dengue fever, chikungunya and Zika.

    pgSIT is a new scalable genetic control system that uses a CRISPR-based approach to engineer deployable mosquitoes that can suppress populations. Males don't transmit diseases so the idea is that as you release more and more sterile males, you can suppress the population without relying on harmful chemicals and insecticides.

    pgSIT differs from "gene drive" systems that could suppress disease vectors by passing desired genetic alterations indefinitely from one generation to the next. Instead, pgSIT uses CRISPR to sterilize male mosquitoes and render female mosquitoes, which spread disease, as flightless. The system is self-limiting and is not predicted to persist or spread in the environment, two important safety features that should enable acceptance for this technology.

    Suppressing mosquito populations with precision guided sterile males, Nature Communications (2021). DOI: 10.1038/s41467-021-25421-w

    https://phys.org/news/2021-09-technology-genetically-disease-spread...

  • Dr. Krishna Kumari Challa

    Study: AI can make better clinical decisions than humans

    There's no harm in getting a second opinion. But what if that second opinion could be generated by a computer, using artificial intelligence? Would it come up with better treatment recommendations than your professional proposes?

    Medical and educational professionals frequently disagree on the effectiveness of behavioral interventions, which may cause people to receive inadequate treatment.

    To find a better way, researchers compiled simulated data from 1,024 individuals receiving treatment for behavioral issues. The researchers then compared the treatment conclusions drawn in each case by five doctoral-level behavior analysts with those produced by a computer model the two academics developed using machine learning.

    The five professionals only came to the same conclusions approximately 75 percent of the time. More importantly, machine learning produced fewer decision-making errors than did all the professionals.

    Given these very positive results, the next step would be to "integrate these models in an app that could automatically make decisions or provide feedback about how treatment is progressing". 

    The goal, the researchers think, should be to use machine learning to facilitate the work of professionals, not actually replace them, while also making treatment decisions more consistent and predictable.

     Marc J. Lanovaz et al, Machine learning to analyze single‐case graphs: A comparison to visual inspection, Journal of Applied Behavior Analysis (2021). DOI: 10.1002/jaba.863

    https://techxplore.com/news/2021-09-ai-clinical-decisions-humans.ht...

  • Dr. Krishna Kumari Challa

    Drugs that mimic effects of cigarette smoke reduce SARS-CoV-2's ability to enter cells

    Researchers have identified a potential reason why lower numbers of COVID cases have appeared amongst smokers compared to non-smokers, even as other reports suggest smoking increases severity of the disease.

    Researchers have identified two drugs that mimic the effect of chemicals in cigarette smoke to bind to a receptor in mammalian cells that inhibits production of ACE2 proteins, a process that appears to reduce the ability of the SARS-CoV-2 virus to enter the cell.

    The findings appear in the journal Scientific Reports on 17 August.

    Something of a paradox exists with respect to smoking cigarettes and COVID-19. Active smoking is associated with increased severity of disease, but at the same time, many reports have suggested lower numbers of COVID cases amongst smokers than amongst non-smokers.

    Something strange was going on here. We must stress the presence of strong evidence showing that smoking increases the severity of COVID-19. But the mechanism now discovered  is worth further investigation as a potential tool to fight SARS-CoV-2 infections.

    --

    It is known that cigarette smoke contains polycyclic aromatic hydrocarbons (PAHs). These can bind to and activate aryl hydrocarbon receptors (AHRs). A receptor is any structure of the surface or inside of a cell that is shaped to receive and bind to a particular substance. AHRs are a type of receptor inside of mammalian cells that is in turn a transcription factor—something that can induce a wide range of cellular activities through its ability to increase or decrease the expression of certain genes.

    Knowing this about the relationship between PAHs and AHRs, the researchers wanted to investigate the effect of drugs that activate AHR on expression of the genes that control production of the ACE2 protein—the infamous receptor protein on the surface of many cells types that works like a lock that the SARS-CoV-2 virus is able to pick. After binding the virus to the ACE2 protein, it can then enter and infect the cell.

    Part 1

  • Dr. Krishna Kumari Challa

    First, the scientists investigated various cell lines to examine their gene expression levels of ACE2. They found that those cells originating in the oral cavity, lungs and liver had the highest ACE2 expression.

    These high-ACE2-expression cells were then subjected to various doses of cigarette-smoke extract (CSE) for 24 hours. After this, the rate of expression of the CYP1A1 gene, which is known to be inducible by CSE, was evaluated. The CSE treatment had induced increased expression of CYP1A1 gene in liver and lung cells in a dose-dependent manner—the greater the dose, the greater the effect. However, this effect was not as pronounced in oral cavity cells. In other words, greater activity of the CYP1A1, less production of the ACE2 receptors—the route that the virus is able to enter cells.

    In order to explain why this was happening in the presence of cigarette smoke, the researchers then used RNA sequencing analysis to investigate what was happening with gene expression more comprehensively. They found that CSE increased the expressions of genes related to a number of key signaling processes within the cell that are regulated by AHR.

    To more directly observe this mechanism by which AHR acts on ACE2 expression, the effects of two drugs that can activate AHR were evaluated on the liver cells. The first, 6‑formylindolo(3,2‑b)carbazole (FICZ) is derivative of the amino acid tryptophan, and the second, omeprazole (OMP), is a medication already widely used in the treatment of acid reflux and peptic ulcers.

    RNA sequencing data suggested that the CYP1A1 gene was strongly induced in liver cells by these AHR activators, and expression of the ACE2 gene was strongly inhibited, again in a dose-dependent manner.

    In other words, the cigarette smoke extract and these two drugs—all of which act as activators of AHR—are able to suppress the expression of ACE2 in mammalian cells, and by doing so, reduce the ability of the SARS-CoV-2 virus to enter the cell.

    Keiji Tanimoto et al, Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal, Scientific Reports (2021). DOI: 10.1038/s41598-021-96109-w

    https://medicalxpress.com/news/2021-09-drugs-mimic-effects-cigarett...

    Part 2

  • Dr. Krishna Kumari Challa

    A new gold standard for detecting cancer mutations

    An international research collaboration has identified a new gold standard for detecting cancer mutations using genomic pathology.

    This research set out to understand why there has been a history of low reproducibility of genomic testing results between different labs when detecting cancers.

    Scientists found factors like sample and library preparation, differing sequencing technology and bioinformatic tools were affecting the reproducibility and performance of the genomic analytical techniques.

    The research team have now developed a set recommendations and guidelines on how to improve the reproducibility and precision of the tumor mutation detection in clinical practice.

    All stages of mutation detection are interdependent and this dependency is complex.

    There is no 'one way' to detect cancerous tumor mutations. For example, the amount of DNA sequencing needed to detect a cancer mutation will vary based on the amount of tumor content.

    Every person is different and should be treated differently. And our research provides a new tool to improve precision medicine.

    Wenming Xiao et al, Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing, Nature Biotechnology (2021). DOI: 10.1038/s41587-021-00994-5

    https://medicalxpress.com/news/2021-09-gold-standard-cancer-mutatio...

  • Dr. Krishna Kumari Challa

     Study reveals that immune cells cooperate to trap and kill bacteria

    Like a spider trapping its prey, our immune system cells cooperate to capture and "eat" bacteria.

    The newly identified antibacterial mechanism, reported Sept. 10 in Science Advances, could inspire novel strategies for combating Staphylococcus aureus (staph) and other extracellular bacterial pathogens.

    It was known that neutrophils—first responder immune cells that migrate to sites of infection—can self-destruct and release their protein and DNA contents to generate neutrophil extracellular traps (NETs). Now, Vanderbilt researchers led by postdoctoral fellow Andrew Monteith, Ph.D., have discovered that NETs boost the bacterial killing power of another type of immune cell: macrophages.

    Neutrophils produce the spider webs that immobilize the bacteria, and macrophages are the spiders that engulf and kill the bacteria. Neutrophils and macrophages are both phagocytic cells known for ingesting bacteria and producing antimicrobial peptides, reactive oxygen species and other enzymes to fight infection. NET generation (NETosis), thought to be a form of programmed cell death, is a more recently discovered neutrophil antibacterial strategy. The released neutrophil DNA creates a sticky trap that is also studded with antimicrobial peptides.

    The macrophages end up with not only their own antibacterial arsenal, but also the neutrophils' antibacterial arsenal, all in the same compartment killing the bacteria.

     Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens, Science Advances (2021). DOI: 10.1126/sciadv.abj2101

    https://phys.org/news/2021-09-caught-web-reveals-immune-cells.html?...

  • Dr. Krishna Kumari Challa

    Why do some plants track the sun?

    Heliotropism,  literally means moving in relation to the sun.

    Sunflowers track the course of the sun spectacularly on warm and sunny, spring or summer days. Sometimes they move through an arc of almost 180⁰ from morning to evening.

    A number flowering species display heliotropism, including alpine buttercups, arctic poppies, alfalfa, soybean and many of the daisy-type species. So why do they do it?

    Flowers are really in the advertising game and will do anything they can to attract a suitable pollinator, as effectively and as efficiently as they can. There are several possible reasons why tracking the sun might have evolved to achieve more successful pollination.

    By tracking the sun, flowers absorb more solar radiation and so remain warmer. The warmer temperature suits or even rewards insect pollinators that are more active when they have a higher body temperature.

    Optimum flower warmth may also boost pollen development and germination, leading to a higher fertilization rate and more seeds.

    So, the flowers are clearly moving. But how?

    For many heliotropic flowering species, there's a special layer of cells called the pulvinus just under the flower heads. These cells pump water across their cell membranes in a controlled way, so that cells can be fully pumped up like a balloon or become empty and flaccid. Changes in these cells allow the flower head to move.

    When potassium from neighboring plant cells is moved into the cells of the pulvinus, water follows and the cells inflate. When they move potassium out of the cells, they become flaccid.

    These potassium pumps are involved in many other aspects of plant movement, too. This includes the opening and closing of stomata (tiny regulated leaf apertures), the rapid movement of mimosa leaves, or the closing of a fly trap.

    In 2016, scientists discovered that the pin-up example of heliotropism—the sunflower—had a different way of moving.

    They found sunflower movement is due to significantly different growth rates on opposite sides of the flowering stem.

    On the east-facing side, the cells grow and elongate quickly during the day, which slowly pushes the flower to face west as the daylight hours go by—following the sun. At night the west-side cells grow and elongate more rapidly, which pushes the flower back toward the east over night.

    Everything is then set for the whole process to begin again at dawn next day, which is repeated daily until the flower stops growing and movement ceases.

    While many people are aware of heliotropism in flowers, heliotropic movement of leaves is less commonly noticed or known. Plants with heliotropic flowers don't necessarily have heliotropic leaves, and vice versa.

    Part1

  • Dr. Krishna Kumari Challa

    Heliotropism evolves in response to highly specific environmental conditions, and factors affecting flowers can be different from those impacting leaves.

    For example, flowers are all about pollination and seed production. For leaves, it's for maximizing photosynthesis, avoiding over-heating on a hot day or even reducing water loss in harsh and arid conditions.

    Some species, such as the Queensland box, arrange their leaves so they're somewhat horizontal in the morning, capturing the full value of the available sunlight. But there are also instances where leaves align vertically to the sun in the middle of the day to minimize the risks of heat damage.

    It's easy to think of plants as static organisms. But of course, they are forever changing, responding to their environments and growing. They are dynamic in their own way, and we tend to assume that when they do change, it will be at a very slow and steady pace.

    Heliotropism shows us this is not necessarily the case. Plants changing daily can be a little unsettling in that we sense a change but may not be aware of what is causing our unease.

    This article is republished from The Conversation under a Creative Commons license. Read the original article.The Conversation

    https://phys.org/news/2021-09-daily-tracking-sun-fascinating.html?u...

    Part2

  • Dr. Krishna Kumari Challa

    What happens when two very different respiratory viruses infect the same cell

    We know that several viruses infect us. recent study from the University of Glasgow has discovered what happens when you get infected with some of these viruses at the same time, and it has implications for how they make us sick and how we protect ourselves from them.

    For many reasons, respiratory viruses are often found during winter in the temperate regions of the world, or the rainy season of equatorial regions. During these periods, you'll probably be infected with more than one virus at any one time in a situation called a "co-infection."

    Research shows that up to 30% of infections may harbor more than one virus. What this means is that, at some point two different viruses are infecting the cells that line your nose or lungs.

    We know that co-infection can be important if we look at a process called "antigenic shift" in influenza viruses, which is basically caused by virus "sex." This sometimes occurs when two different influenza strains meet up inside the same cell and exchange genes, allowing a new variant to emerge.

    Co-infection can create a predicament for viruses when you consider that they need to compete for the same resource: you. Some viruses appear to block other viruses, while some viruses seem to like each other. What is driving these positive and negative interactions during co-infections is unknown, but animal studies suggest that it could be critical in determining how sick you get.

    The University of Glasgow study investigated what happens when you infect cells in a dish with two human respiratory viruses. For their experiments, they chose IAV and RSV, which are both common and cause lots of disease and death each year. The researchers looked at what happens to each virus using high-resolution imaging techniques, such as cryo-electron microscopy, that their labs have perfected over the years.

    They found that some of the human lung cells in the dish contained both viruses. And, by looking closely at those co-infected cells, they found that the viruses that were emerging from the cell had structural characteristics of both IAV and RSV. The new "chimeric" virus particles had proteins of both viruses on their surface and some even contained genes from the other. This is the first evidence of this occurring from co-infection of distinct respiratory viruses.

    Follow-up experiments in the same paper showed that these new chimeric viruses were fully functional and could even infect cells that were rendered resistant to influenza, presumably gaining access using the RSV proteins could even get into a broader range of human cells than either virus alone could. Potentially, this could be happening during natural co-infections during the winter.

    https://www.biorxiv.org/content/10.1101/2021.08.16.456460v2

    https://theconversation.com/heres-what-happens-when-two-very-differ...

  • Dr. Krishna Kumari Challa

    Animals shape shifting as climate warms

    Some animals are "shape-shifting" and have developed bigger tails, beaks and ears to regulate their body temperatures as the planet warms, according to a new study. From Australian parrots to European rabbits, researchers found evidence that a host of warm-blooded animals have evolved bigger body parts, which could allow them to lose body heat more effectively. Climate change is heaping "a whole lot of pressure" on animals. It's high time we recognised that animals also have to adapt to these changes, but this is occurring over a far shorter timescale than would have occurred through most of evolutionary time. The study, published on recently  in the journal Trends in Ecology and Evolution, reviewed previous research "where climatic warming is a potential hidden explanatory variable for the occurrence of shape-shifting" and found trends particularly noticeable in birds.

    The Australian parrot, for example, had shown an average 4-10 percent increase in the size of its bill since 1871 and the authors said this positively correlated with the summer temperature each year.

    Other birds, like North American dark-eyed juncos, thrushes and Galapagos finches also saw bill size increases.

    Meanwhile, the wings of the great roundleaf bat grew, the European rabbit developed bigger ears, while the tails and legs of masked shrews were found to be larger.

    Shape-shifting does not mean that animals are coping with climate change and that all is 'fine'. It just means they are evolving to survive it -- but we're not sure what the other ecological consequences of these changes are, or indeed that all species are capable of changing and surviving.

    It's well known that animals use their appendages to regulate their internal temperature. African elephants, for example, pump warm blood to their large ears, which they then flap to disperse heat.

    The beaks of birds perform a similar function – blood flow can be diverted to the bill when the bird is hot. This heat-dispersing function shows the beak is warmer than the rest of the body. All this means there are advantages to bigger appendages in warmer environments.

    warm-blooded animals – also known as endotherms – tended to have smaller appendages while those in warmer climates tend to have larger ones.

    This pattern became known as Allen's rule, which has since been supported by studies of birds  and mammals.

    Biological patterns such as Allen's rule can also help make predictions about how animals will evolve as the climate warms.

    https://www.cell.com/trends/ecology-evolution/fulltext/S0169-5347(21)00197-X?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS016953472100197X%3Fshowall%3Dtrue

    https://researchnews.cc/news/8818/Animals--shape-shifting--as-clima...

  • Dr. Krishna Kumari Challa

    Cannibalistic butterflies chow down on live caterpillars

    For the first time, milkweed butterflies have been seen harassing, subduing and then slurping up the juices of caterpillars.

    We generally think of butterflies s as beautiful, harmless, nectar-drinking insects. But new research carried out by the University of Sydney may change all that, as milkweed butterflies have been spotted scratching at caterpillars with their sharp claws to suck up their juices.

    Milkweed butterflies are a group of butterflies in the Nymphalidae family, with one well-known species being the monarch butterfly.

    As caterpillars, milkweed butterflies feed on toxic plants, using the chemicals as self-defence to make them unpalatable to birds and other predators. When the caterpillars turn into butterflies, they retain these toxins and advertise that they are poisonous with their bright colours.

    Male butterflies will also use these toxic substances to produce mating pheromones. In order to boost their supplies of these love drugs, they’ll seek out extra sources of the chemicals.

    Generally, they get these through plants, but in North Sulawesi, Indonesia, they have developed a taste for caterpillars – and they don’t care whether they are alive or dead.

    “This is the first time the behaviour has been reported.

    https://esajournals.onlinelibrary.wiley.com/doi/10.1002/ecy.3532

    https://www.sciencefocus.com/news/cannibalistic-butterflies-chow-do...

  • Dr. Krishna Kumari Challa

    An Alternative to Injection

    Research on microneedle patches for vaccine delivery has grown in popularity in recent years, due to their exceptional compliance and low invasiveness.

    Several researchers, including ourselves, are working on a technology that aims to provide the advantages of injectable vaccines without the drawbacks—and without the traditional needle stick: microneedles. While the technology still has a long road to the clinic, having entered human trials less than 10 years ago, we believe this it is the future of vaccine delivery, and the ongoing pandemic has highlighted the need to accelerate its development.

    Basically, an array of tiny needles measuring just hundreds of microns is attached to a backing, permitting bandage-like application. Drugs can be encapsulated within water-soluble microneedles that dissolve when the patch is placed on the skin, allowing the drug to be released. Importantly, the microneedles pierce the outermost layer of tissue to allow greater absorption of the drugs compared to creams or other kinds of medical patches such as nicotine patches, but they do not penetrate deep enough to stimulate pain receptors. The patch can be self-administered and is as easy and painless as taking a pill. 

    The patch has its limitations. Being such a small medical device, for example, the maximum drug dose is less than 1 mg. But for treatments that do not require a high dosage, including vaccines (both antigen-based ones and nanoparticle ones, such as those used for mRNA vaccines against COVID-19), hormones, and drugs with elevated potency, microneedles are ideal. In addition to being user friendly, microneedles could elicit a more robust immunological response. 

    Conventional vaccine injection bypasses the skin’s immune system and introduces the antigen into the muscle or subcutaneous tissue, thereby inducing a systemic immune response. Yet, the skin, our biggest organ, also has a superb immunogenicity capacity due to the presence of many antigen-presenting cells. By delivering antigens there, microneedles could capitalize on this local response to boost the protection provided by vaccines. Indeed, animal studies suggest that microneedles elicit higher antibody production and better cellular response.

    part 1

  • Dr. Krishna Kumari Challa

  • Dr. Krishna Kumari Challa

    Moreover, because microneedles are a dry formulation, they allow drugs to maintain their activity even without storing them at the low temperatures required of many injectable vaccines. For example, one study has shown that a vaccine for influenza can be stable for six months at 25 °C and at least a few weeks at 40 °C if incorporated into microneedles. This is critical for ensuring vaccinations reach far-flung corners of the world that do not have the resources to maintain the cold chain. 

    Another issue is vaccine wastage. For example, in some cases only a portion of the dose is used before a vaccine expires. It can also happen that healthcare personnel decide not to vaccinate a patient when there are not enough patients to use the whole vial. According to estimates, the wastage rates for 10-dose vials may be as high as 25 percent for liquid vaccines and 40 percent for freeze-dried vaccines. With microneedle patches, there is no wasted drug. And there are no needles that require special disposal procedures.

    There are plenty of hurdles yet to be overcome. We need further clinical studies in human volunteers to demonstrate safety and efficacy of this vaccine approach, and the scale-up of production is still in its infancy. On a lab scale, usually we fill molds with the polymer solutions via vacuum or centrifugation. Once dried, the final formulation is demolded and secured to a backing. This is tedious and not practical for mass production.

    Additionally, the majority of vaccinations are sterilized by filtering, which is not feasible for solid microneedle patches. While the solution may be sterilized before being placed in the molds, the final product will also need to undergo sterilization by some alternative technique not yet developed. 

    The recent pandemic and the possibility of others is a wake-up call to focus on these challenges. In the last year and a half, several institutions and biotech companies announced preclinical studies for a SARS-CoV-2 vaccine utilizing microneedle patches. Big pharmaceutical companies will certainly step up and invest more over the coming years in microneedle-based products. Injections have been used for centuries, but the necessity for a worldwide immunization effort is a persuasive reason to try to move forward. 

    https://www.the-scientist.com/news-opinion/opinion-an-alternative-t...

    part3

  • Dr. Krishna Kumari Challa

    Researchers  discover river of dust around the sun

    A team of researchers has discovered a dusty mystery in a newly explored region around Earth’s sun.  They noticed a new and unexplained stream of microscopic particles that seemed to be spraying out from around the star.

    Dust can come from asteroids and comets or can be left over from the original formation of the planets. It can show us how our solar system has formed and continues to evolve and even how other solar systems may be evolving.

    There are two basic types of dust around the sun. Dust that is in bound orbits around the sun that will eventually spiral into the sun. Then there’s unbound dust that is flung away and out of the solar system.

    No one had seen anything like this third type before—dust flying away from the sun usually spreads out in every direction. It doesn’t tend to cluster together like this one. 

    https://iopscience.iop.org/article/10.3847/PSJ/ac0bb9

    https://researchnews.cc/news/8866/Researchers-led-by-undergraduate-...

  • Dr. Krishna Kumari Challa

    How Old Are Stars? An  Astrophysicist Unlocks the Secrets of Age-Dating

  • Dr. Krishna Kumari Challa

    Black holes found to exert a pressure on their environment

    Physicists have discovered that black holes exert a pressure on their environment, in a scientific first.

    In 1974 Stephen Hawking made the seminal discovery that black holes emit thermal radiation. Previous to that, black holes were believed to be inert, the final stages of a dying heavy star.

    Now scientists have shown that they are in fact even more complex thermodynamic systems, with not only a temperature but also a pressure.

     Quantum gravity  can lead to a pressure in black holes. This  finding that Schwarzschild black holes have a pressure as well as a temperature is more surprising. 

    Xavier Calmet et al, Quantum gravitational corrections to the entropy of a Schwarzschild black hole, Physical Review D (2021). DOI: 10.1103/PhysRevD.104.066012

    https://phys.org/news/2021-09-black-holes-exert-pressure-environmen...

  • Dr. Krishna Kumari Challa

    Ancient marsupial ‘junk DNA’ might be useful after all, scientists say

  • Dr. Krishna Kumari Challa

    CDC finds unvaccinated 11 times more likely to die of COVID

    New U.S. studies released Friday show the COVID-19 vaccines remain highly effective against hospitalizations and death even as the extra-contagious delta variant swept the country.

    One study tracked over 600,000 COVID-19 cases in 13 states from April through mid-July. As delta surged in early summer, those who were unvaccinated were 4.5 times more likely than the fully vaccinated to get infected, over 10 times more likely to be hospitalized and 11 times more likely to die, according to the Centers for Disease Control and Prevention.

    Vaccination works! But ...

    But as earlier data has shown, protection against coronavirus infection is slipping some: It was 91% in the spring but 78% in June and July, the study found.

    So-called "breakthrough" cases in the fully vaccinated accounted for 14% of hospitalizations and 16% of deaths in June and July, about twice the percentage as earlier in the year.

    An increase in those percentages isn't surprising: No one ever said the vaccines were perfect.

    Source: Agence France-Presse

    https://medicalxpress.com/news/2021-09-cdc-unvaccinated-die-covid.h...

    https://researchnews.cc/news/8872/Covid-vaccines-hold-up-against-se...

  • Dr. Krishna Kumari Challa

    Self‐care tooling innovation in a disabled kea (Nestor notabilis)

  • Dr. Krishna Kumari Challa

    Situs inversus totalis involves complete transposition (right to left reversal) of the thoracic and abdominal organs. 

    The heart is not in its usual position in the left chest, but is on the right. Specifically related to the heart, this is referred to as dextrocardia (literally, right-hearted).The stomach, which is normally in the left upper abdomen, is on the right. In patients with situs inversus totalis, all of the chest and abdominal organs are reversed and appear in mirror image when examined or visualized by tests such as X-ray filming. Situs inversus totalis has been estimated to occur once in about 6-8,000 births. Situs inversus occurs in a rare abnormal condition that is present at birth (congenital) called Kartagener's syndrome.

  • Dr. Krishna Kumari Challa

    Gut flora composition may impact susceptibility to konzo, a neurological disease caused by world staple crop cassava

    Konzo is a severe, irreversible neurologic disease that results in paralysis. It occurs after consuming poorly processed cassava -- a manioc root and essential crop for DRC and other low-income nations. Poorly processed cassava contains linamarin, a cyanogenic compound. While enzymes with glucosidase activity convert starch to simple sugars, they also break down linamarin, which then releases cyanide into the body.

     Differences between gut flora and genes from konzo-prone regions of the Democratic Republic of Congo (DRC) may affect the release of cyanide after poorly processed cassava is consumed, according to a study with 180 children. Cassava is a food security crop for over half a billion people in the developing world. Children living in high-risk konzo areas have high glucosidase (linamarase) microbes and low rhodanese microbes in their gut, which could mean more susceptibility and less protection against the disease, suggest  researchers who led the study published in Nature Communications.

    Knowing who is more at risk could result in targeted interventions to process cassava better or try to diversify the diet. An alternative intervention is to modify the microbiome to increase the level of protection. This is, however, a difficult task which may have unintended consequences and other side effects.

    While the gut microbiome is not the sole cause of disease given that environment and malnourishment play a role, it is a required modulator. "Simply stated, without gut microbes, linamarin and other cyanogenic glucosides would pose little to no risk to humans."

    1. Matthew S. Bramble, Neerja Vashist, Arthur Ko, Sambhawa Priya, Céleste Musasa, Alban Mathieu, D’ Andre Spencer, Michel Lupamba Kasendue, Patrick Mamona Dilufwasayo, Kevin Karume, Joanna Nsibu, Hans Manya, Mary N. A. Uy, Brian Colwell, Michael Boivin, J. P. Banae Mayambu, Daniel Okitundu, Arnaud Droit, Dieudonné Mumba Ngoyi, Ran Blekhman, Desire Tshala-Katumbay, Eric Vilain. The gut microbiome in konzo. Nature Communications, 2021; 12 (1) DOI: 10.1038/s41467-021-25694-1
  • Dr. Krishna Kumari Challa

    A Clever 'Gene Silencing' Injection Has Been Approved For Treating High Cholesterol

    cholesterol-busting jab to save thousands of lives in UK

    The revolutionary new treatment, Inclisiran, is delivered as an injection twice a year and can be used alongside statins, adding to the options available to patients to help control their cholesterol levels.

    It has been estimated that Inclisiran could prevent 55,000 heart attacks and strokes, saving 30,000 lives within the next decade.

    It will mainly be prescribed to patients who suffer with a genetic condition that leads to high cholesterol, those who have already suffered a heart attack or stroke, or those who haven't responded well to other cholesterol-lowering drugs, such as statins.

    This is an emerging therapeutic technique that works by targeting the underlying causes of a disease, rather than the symptoms it causes. It does this by targeting a particular gene, and preventing it from making the protein that it produces.

    Until now, most treatments using gene silencing technology have been used to treat rare genetic diseases. This means the cholesterol jab will be one of the first gene silencing drugs used to treat people on a wider scale.

    Researchers are also currently investigating whether gene silencing could be used to treat a wide variety of health conditions, including Alzheimer's disease and cancer.

    Gene silencing drugs work by targeting a specific type of RNA (ribonucleic acid) in the body, called "messenger" RNA. RNAs are found in every cell of the body, and play an important role in the flow of genetic information.

    But messenger RNA (mRNA) is one of the most important types of RNA our body has, as it copies and carries genetic instructions from our DNA and makes specific proteins depending on the instructions.

    In the case of the cholesterol jab, gene silencing works by targeting a protein called PCSK9 and degrading it. This protein is involved in regulating cholesterol in our bodies, but occurs in excess in people with high levels of LDL cholesterol (the "bad" cholesterol). Preventing this protein from being produced in the first place will reduce cholesterol levels.

    https://www.england.nhs.uk/2021/09/nhs-cholesterol-busting-jab-to-s...

  • Dr. Krishna Kumari Challa

    In this case, the siRNA is designed to specifically target the mRNA which carries instructions for the PCSK9 protein. It binds to its target mRNA and destroys the instructions, which significantly reduces the amount of these proteins that are produced.

    Gene therapies are usually delivered using a viral vector – a virus-like vehicle that delivers genes to our cells in the same way a virus might infect them. So far, viral vector therapies have been used to treat rare genetic blood disorders, genetic blindness and spinal muscular atrophy.

    Although viral vectors are very effective with one treatment, it may be impossible to deliver a second dose if needed due to adverse immune reactions. These drugs are also extremely costly.

    Because of this, many of the gene silencing drugs currently being investigated are delivered using a different technique. Known as non-viral vector gene therapies, these deliver the drug using a nanoparticle which protects it from degradation in the blood so it can be delivered specifically to the target – such as the liver, which is the target of the cholesterol jab.

    https://www.sciencealert.com/this-gene-silencing-injection-was-just...

    Part 2

  • Dr. Krishna Kumari Challa

    Our mobile phones are covered in bacteria and viruses… and we never wash them

  • Dr. Krishna Kumari Challa

    Mechanical buckling of petals produces iridescent patterns visible to bees

    Flowers are employing a materials science phenomenon typically associated with failures in structural engineering to produce exquisite three-dimensional petal patterns to lure pollinators.

    In civil engineering "buckling" is a dirty word with the buckling of beams and columns leading to mechanical failure—and is something that engineers want to avoid.

    But for some plants, buckling is being employed to advantage.

    Flowers use several different strategies to lure pollinators. Chemical color from pigments is just one of these strategies and recent research is finding that iridescence could be just as important for attracting pollinators like bees.

    This optical effect is produced by an intricate pattern of nano-scale ridges on the surface of petals that diffract light to cause iridescence, like that seen on the surface of CDs or soap bubbles, but how the plant develops these ridges was not known.

    Research from the University of Cambridge has demonstrated that plants employ buckling to precisely alter the deformation of the surface of petals in hibiscus flowers. The findings are published in Cell Reports today.

    Mechanical buckling can pattern the light-diffracting cuticle of Hibiscus trionum, Cell Reports (2021). DOI: 10.1016/j.celrep.2021.109715

    https://phys.org/news/2021-09-mechanical-buckling-petals-iridescent...

  • Dr. Krishna Kumari Challa

    People only pay attention to new information when they want to

    A new paper in the Journal of the European Economic Association, published by Oxford University Press, indicates that we tend to listen to people who tell us things we'd like to believe and ignore people who tell us things we'd prefer not to be true. As a result, like-minded people tend to make one another more biased when they exchange beliefs with one another.

    While it would reasonable to think that people form decisions based on evidence and experience alone, previous research has demonstrated that decision makers have "motivated beliefs;" They believe things in part because they would like such things to be true. Motivated beliefs (and the reasoning that leads to them) can generate serious biases. Motivated beliefs have been speculated to explain the proliferation of misinformation on online forums.

    The experiment conducted supports a lot of popular suspicions about why biased beliefs might be getting worse in the age of the internet. We now get a lot of information from social media and we don't know much about the quality of the information we're getting. As a result, we're often forced to decide for ourselves how accurate various opinions and sources of information are and how much stock to put in them. Our results suggest that people resolve this quandary by assigning credibility to sources that are telling us what we'd like to hear and this can make biases due to motivated reasoning a lot worse over time.

    Ryan Oprea et al, Social Exchange of Motivated Beliefs, Journal of the European Economic Association (2021). DOI: 10.1093/jeea/jvab035

    https://phys.org/news/2021-09-people-attention.html?utm_source=nwle...

  • Dr. Krishna Kumari Challa

    Study links severe COVID-19 to increase in self-attacking antibodies

    Hospitalized COVID-19 patients are substantially more likely to harbor autoantibodies—antibodies directed at their own tissues or at substances their immune cells secrete into the blood—than people without COVID-19, according to a new study.

    Autoantibodies can be early harbingers of full-blown autoimmune disease.

    If you get sick enough from COVID-19 to end up in the hospital, you may not be out of the woods even after you recover.

    The scientists looked for autoantibodies in blood samples drawn during March and April of 2020 from 147 COVID-19 patients at the three university-affiliated hospitals and from a cohort of 48 patients at Kaiser Permanente in California. Blood samples drawn from other donors prior to the COVID-19 pandemic were used as controls.

    The researchers identified and measured levels of antibodies targeting the virus; autoantibodies; and antibodies directed against cytokines, proteins that immune cells secrete to communicate with one another and coordinate their overall strategy.

    Upward of 60% of all hospitalized COVID-19 patients, compared with about 15% of healthy controls, carried anti-cytokine antibodies, the scientists found. This could be the result of immune-system overdrive triggered by a virulent, lingering infection. In the fog of war, the abundance of cytokines may trip off the erroneous production of antibodies targeting them.

    If any of these antibodies block a cytokine's ability to bind to its appropriate receptor, the intended recipient immune cell may not get activated. That, in turn, might buy the virus more time to replicate and lead to a much worse outcome.

    Part1

  • Dr. Krishna Kumari Challa

    In some cases, the presence of those newly detected autoantibodies may reflect an increase, driven by the immune response, of antibodies that had been flying under the radar at low levels, Utz said. It could be that inflammatory shock to the systems of patients with severe COVID-19 caused a jump in previously undetectable, and perhaps harmless, levels of autoantibodies these individuals may have been carrying prior to infection.

    In other cases, autoantibody generation could result from exposure to viral materials that resemble our own proteins.

    --

    It's possible that, in the course of a poorly controlled SARS-CoV-2 infection—in which the virus hangs around for too long while an intensifying immune response continues to break viral particles into pieces—the immune system sees bits and pieces of the virus that it hadn't previously seen," he said. "If any of these viral pieces too closely resemble one of our own proteins, this could trigger autoantibody production."

    The finding bolsters the argument for vaccination. Vaccines for COVID-19 contain only a single protein—SARS-CoV-2's so-called spike protein—or the genetic instructions for producing it. With vaccination, the immune system is never exposed to—and potentially confused by—the numerous other novel viral proteins generated during infection.

    In addition, vaccination is less intensely inflammatory than an actual infection, so there's less likelihood that the immune system would be confused into generating antibodies to its own signaling proteins or to the body's own tissues.

    Patients who, in response to vaccination, quickly mount appropriate antibody responses to the viral spike protein should be less likely to develop autoantibodies.

    Indeed, a recent study in Nature showed that, unlike SARS-CoV-2 infection, the COVID-19 vaccine produced by Pfizer doesn't trigger any detectable generation of autoantibodies among recipients.

    1. Sarah Esther Chang, Allan Feng, Wenzhao Meng, Sokratis A. Apostolidis, Elisabeth Mack, Maja Artandi, Linda Barman, Kate Bennett, Saborni Chakraborty, Iris Chang, Peggie Cheung, Sharon Chinthrajah, Shaurya Dhingra, Evan Do, Amanda Finck, Andrew Gaano, Reinhard Geßner, Heather M. Giannini, Joyce Gonzalez, Sarah Greib, Margrit Gündisch, Alex Ren Hsu, Alex Kuo, Monali Manohar, Rong Mao, Indira Neeli, Andreas Neubauer, Oluwatosin Oniyide, Abigail E. Powell, Rajan Puri, Harald Renz, Jeffrey Schapiro, Payton A. Weidenbacher, Richard Wittman, Neera Ahuja, Ho-Ryun Chung, Prasanna Jagannathan, Judith A. James, Peter S. Kim, Nuala J. Meyer, Kari C. Nadeau, Marko Radic, William H. Robinson, Upinder Singh, Taia T. Wang, E. John Wherry, Chrysanthi Skevaki, Eline T. Luning Prak, Paul J. Utz. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nature Communications, 2021; 12 (1) DOI: 10.1038/s41467-021-25509-3

    https://medicalxpress.com/news/2021-09-links-severe-covid-self-atta...

    part 2

  • Dr. Krishna Kumari Challa

    Researchers find immune cells that guard frequent site of cancer spread

    In the progressing field of immunotherapy, surprisingly little is known about immunity to metastatic tumors in locations such as lymph nodes, a frequent place where cancers first spread. Not only do lymph nodes act as a gateway for cancer cells to travel throughout the body, but they are also home to infection-fighting white blood cells called T cells. In some cases, T cells in lymph nodes activate to kill invading cancer cells. In other cases, that process clearly fails.

    While T cells can freely travel from lymph nodes into the bloodstream and back to the lymph nodes, researchers in Turk's lab have discovered a novel population of tumor-fighting T cells that do not circulate, but rather stay in lymph nodes where they provide protection against melanoma. "These T cells, for whatever reason, have changed their program and stay in the lymph nodes where they persist and kill tumor cells for many months while never entering circulation," says Turk.

    These long-lived T cells, called "lymph node resident memory T cells," were shown to counteract melanoma spreading in mice. Turk's team found that when melanoma cells were put back into mice that had been cured of cancer with immunotherapy a month earlier, the lymph nodes were still resistant to the cancer—the melanoma would not grow.

    Researchers identified T cells with similar characteristics in melanoma-invaded patient lymph nodes, showing that similar populations exist in humans.

    Computational analysis of melanoma specimen data from The Cancer Genome Atlas revealed that the presence of T cells with this gene signature predicted better outcomes and improved survival for human melanoma patients with lymph node metastases. "These studies reveal a new population of T cells that is vital for counteracting the earliest stages of cancer metastasis.

    Resident memory T cells in regional lymph nodes mediate immunity to metastatic melanoma, ImmunityDOI: 10.1016/j.immuni.2021.08.019

    https://medicalxpress.com/news/2021-09-immune-cells-frequent-site-c...

    **

  • Dr. Krishna Kumari Challa

    Scientists pinpoint the uncertainty of our working memory

    The human brain regions responsible for working memory content are also used to gauge the quality, or uncertainty, of memories, a team of scientists has found. Its study uncovers how these neural responses allow us to act and make decisions based on how sure we are about our memories.

    Access to the uncertainty in our working memory enables us to determine how much to 'trust' our memory in making decisions.

    This research is the first to reveal that the neural populations that encode the content of working memory also represent the uncertainty of memory.

    Working memory, which enables us to maintain information in our minds, is an essential cognitive system that is involved in almost every aspect of human behavior—notably decision-making and learning.

    For example, when reading, working memory allows us to store the content we just read a few seconds ago while our eyes keep scanning through the new sentences. Similarly, when shopping online, we may compare, "in our mind," the item in front of us on the screen with previous items already viewed and still remembered.

    "It is not only crucial for the brain to remember things, but also to weigh how good the memory is: How certain are we that a specific memory is accurate?

     The study results yielded the first evidence that the human brain registers both the content and the uncertainty of working memory in the same cortical regions.

    The knowledge of uncertainty of memory also guides people to seek more information when we are unsure of our own memory.

    Joint representation of working memory and uncertainty in human cortex, Neuron (2021). DOI: 10.1016/j.neuron.2021.08.022

    https://medicalxpress.com/news/2021-09-scientists-uncertainty-memor...

  • Dr. Krishna Kumari Challa

    New immunotherapy method turns activated specifically in tumor

    Immunotherapy drugs are promising new weapons in the fight against cancer, but they are so strong that they can be toxic to the rest of the human body. The basic idea behind immunotherapy drugs is simple. Doctors inject special kinds of drugs, especially proteins such as antibodies and cytokines prepared or modified in a lab, into a patient, where they activate the patient’s immune cells –T-cells, NK cells, and so on – and help these cells fight the tumor. In short, immunotherapy drugs work like a powerful cocktail that boosts a patient’s own immune system.

    After being prescribed by a doctor, immunotherapy drugs are administered intravenously.

    Once inside the body, the drugs spread all over – not just where the tumor or any metastases are located. The problem is that the proteins in the drugs are so strong that they damage healthy tissue. Many of the immunotherapy treatments already out there have proven to be highly effective against cancer in preclinical studies. But they often can’t be used to save people because they’re too toxic to the rest of the body. The treatments that are used in patients today have been toned down so they’re less potent. That makes them safer, but also less effective at destroying tumors. The aim of this new method is to keep all the potency of immunotherapy, because it will be an important treatment option for cancer patients.
    Researchers, therefore, developed a method whereby the immunotherapy proteins are activated only when they come into the tumor tissues.  This method draws on techniques from both chemistry and immune engineering.

    The tumor microenvironment is different from the rest of the body. The pH is lower, meaning it’s more acidic, and it has a high reducing potential. Researchers used these facts, already known to scientists, to develop a kind of polymer shield for the protein drugs that would let them travel harmlessly through the body until they reach the tumor.

    That shield is designed to break down when exposed to the unique chemical environment in the tumor tissue. Chemical reactions in the tumour microenvironment break the bonds at the protein surface, thereby removing the polymer shield. The protein drugs are then free to activate the patient’s cancer-fighting lymphocytes selectively in the tumour tissue.

    Zhao, Y. ; Xie, Y.-Q. ; Van Herck, S. ; Nassiri, S. ; Gao, M. ; Guo...

    https://actu.epfl.ch/news/new-immunotherapy-becomes-activated-speci...

    https://www.myscience.ch/en/news/2021/new_immunotherapy_becomes_act...

    https://researchnews.cc/news/8892/New-immunotherapy-method-turns-ac...

  • Dr. Krishna Kumari Challa

    Chemically masked cytokines and antibodies turn active selectively in tumors as safer cancer immunotherapies. Credit: Yu Zhao 2021 EPFL

  • Dr. Krishna Kumari Challa

  • Dr. Krishna Kumari Challa

    How to modify RNA: Crucial steps for adding chemical tag to transfer RNA revealed

    The chemical steps in an important cellular modification process that adds a chemical tag to some RNAs have been revealed in a new study. Interfering with this process in humans can lead to neuronal diseases, diabetes, and cancers. A research team has imaged a protein that facilitates this RNA modification in bacteria, allowing the researchers to reconstruct the process. A paper describing the modification process appears Sept. 15 in the journal Nature.

    Transfer RNAs (tRNA) are the RNAs that "read" the genetic code and translate it into a sequence of amino acids to make a protein. The addition of a chemical tag—a methyl sulfur group—to a particular location on some tRNAs improves their ability to translate messenger RNA into proteins. When this modification process—called methylthiolation—doesn't occur properly, mistakes can be incorporated into the resulting proteins, which in humans can lead to neuronal disease, cancer, and increased risk of developing Type 2 diabetes.

    Methylthiolation is ubiquitous across bacteria, plants, and animals. In this study, researchers  determined the structure of a protein called MiaB to better understand its role in facilitating this important modification process in bacteria.

    Structural basis for tRNA methylthiolation by the radical SAM enzyme MiaB, Nature (2021). DOI: 10.1038/s41586-021-03904-6 , www.nature.com/articles/s41586-021-03904-6

    https://phys.org/news/2021-09-rna-crucial-adding-chemical-tag.html?...

  • Dr. Krishna Kumari Challa

    Differences in cellular signaling offer clues to insulin resistance

    In what could be a starting point for new therapeutics to tackle insulin resistance, a major driver of type 2 diabetes and metabolic syndrome present in 20–30 percent of the general U.S. population, researchers recently found that insulin resistance in the general population seems likely to be caused by a series of cell-specific signaling defects, some of which appear to be sex specific.

    In addition, only a portion of the defects are shared with those seen in diabetes, pointing towards the existence of novel pathways behind insulin resistance in the general population.

    Most people know that insulin is an important hormone for controlling blood glucose, but most people don't realize how important insulin is for all aspects of metabolism—not just sugar, but lipids, amino acids, and proteins

    Insulin resistance, that is the failure of the body to respond normally to insulin, is very common in the population, not just in people with diabetes or obesity, and these individuals are at high risk for developing these metabolic disorders.

    The research is based on a stem-cell modeling system called iMyos that can be used to investigate cell-specific changes in signaling in combination with a technique called phosphoproteomics.

    Specifically, the researchers used stem cells derived from blood cells of individuals without diabetes who were either insulin sensitive or resistant.

    The researchers could then investigate differences in cellular signaling, both in the absence and presence of insulin stimulation, to determine how insulin resistance or sensitivity affected signaling in a series of different pathways.

    In what emerges as a complex picture, they found large differences in phosphoproteome signatures based on insulin sensitivity status but also based on the sex of the cell donors.

    Nida Haider et al, Signaling defects associated with insulin resistance in non-diabetic and diabetic individuals and modification by sex, Journal of Clinical Investigation (2021). DOI: 10.1172/JCI151818

    Part 1

    **

  • Dr. Krishna Kumari Challa

    Researchers identified a comprehensive network of cell signaling defects in non-diabetic individuals and also uncovered critical nodes of signaling changes shared with type 2 diabetic patients.

    These critical nodes where signaling was altered go well beyond the classical insulin signaling, opening a whole new view of insulin resistance. One of the most striking and surprising findings was that many of the signaling changes were sex specific.

    Thus, even in the absence of adding sex hormones, these male and female cells showed differences in their phosphoproteome fingerprint. This was very unexpected.

    Importantly, the investigators also found that the differences and changes did reflect on multiple downstream biological processes, implying that therapeutic interventions at specific points in the signaling cascade will likely affect biological outcomes.

    "Further investigation will be needed to identify the regulators that are responsible for the phosphoproteome changes associated with insulin resistance, and for the drastic differences by sex. "Unraveling these critical nodes in insulin resistance will be able to serve as novel targets for the development of future therapies."

    https://medicalxpress.com/news/2021-09-differences-cellular-clues-i...

    Part 2

  • Dr. Krishna Kumari Challa

    You will no longer need a password for Microsoft accounts

    Microsoft announced in a blog post recently that it will give users the option to access their accounts without using a password.

    Users can choose between downloading the Microsoft Authenticator app - a security key a verification code sent to your phone or secondary email address, or Windows Hello, a biometric option that involves scanning your face, iris or fingerprint.

    With the Authenticator app, for example, users get notified on their smartphone during a login attempt, and receive a prompt confirming their identity.

    The new option tackles two problems: complex passwords people can't remember and passwords that do not offer enough security because they're too simple.

    The feature will be rolled out in the coming weeks.

    https://www.microsoft.com/insidetrack/blog/no-more-passwords-the-re...

  • Dr. Krishna Kumari Challa

    Alzheimer’s disease: hyperbaric oxygen proposed as treatment in new study

    Alzheimer’s disease, the most common form of dementia, has long been associated with a build-up of plaques (clumps of protein) in the brain. Scientists in Israel have shown that a type of oxygen therapy can stop new plaques forming and even remove existing plaques in mice with Alzheimer’s.

    The scientists used a mouse model of Alzheimer’s disease called 5xFAD. The genetically modified mice were treated with hyperbaric oxygen therapy to see if they could halt or slow the disease progression.

    Hyperbaric oxygen therapy involves breathing pure oxygen in a pressurised chamber. In the chamber, the air pressure is increased two to three times higher than normal air pressure. It is commonly used to treat decompression sickness (a condition scuba divers can suffer from), carbon monoxide poisoning, and some forms of stroke or brain injury. It works by forcing increased oxygenation of tissues with low oxygen levels (hypoxia). And it could improve blood flow to the brain to nourish brain cells that are usually deprived of blood, and hence oxygen, in Alzheimer’s disease.

    The scientists, from the University of Tel Aviv, treated 15 six-month-old mice (about 30 human years) with hyperbaric oxygen therapy for an hour a day, five days a week for four weeks. The therapy not only reduced the number and size of plaques in the brains of the mice, it also slowed the formation of new plaques, compared with a control group of mice who did not receive hyperbaric oxygen therapy.

    Blood flow to the brain is reduced in people with Alzheimer’s. This study showed increased blood flow to the brain in the mice receiving oxygen therapy, which helps with the clearance of plaques from the brain, and reduces inflammation – a hallmark of Alzheimer’s.

    By improving blood flow to the brain, reducing plaque levels and reducing hypoxia, the mice undergoing daily oxygen therapy began to show improvements to their cognitive abilities, such as their spatial recognition memory as well as contextual memory – the ability to remember emotional, social, spatial or temporal circumstances related to an event.

    The researchers then used these findings to assess the effectiveness of oxygen therapy in six people over the age of 65 with cognitive decline. They found that 60 sessions of oxygen therapy, over 90 days, increased blood flow in certain areas of the brain and significantly improved the patients’ cognitive abilities – improved memory, attention and information processing speed.

    Taken together, these findings suggest that oxygen therapy may be able to reduce cognitive decline associated with ageing and dementia in both mice and people.

    https://www.aging-us.com/article/203485/text

    https://theconversation.com/alzheimers-disease-hyperbaric-oxygen-pr...

  • Dr. Krishna Kumari Challa

    Ancient marsupial ‘junk DNA’ might be useful after all, scientists say

  • Dr. Krishna Kumari Challa

    For The First Time, Scientists Have Entangled Three Qubits on Silicon

    Scientists have got three entangled qubits operating together on a single piece of silicon.

    It's the first time that's ever been done, and the silicon material is important: that's what the electronics inside today's computers are based on, so it's another advancement in  bridging the gap between the quantum and classical computing realms.

    Qubits are the quantum equivalent of the standard bits inside a conventional computer: they can represent several states at once, not just a 1 or a 0, which – in theory – means an exponential increase in computing power.

    The real magic happens when these qubits are entangled, or tightly linked together.

    As well as increases in computing power, the addition of more qubits means better error correction – a key part of keeping quantum computers stable enough to use them outside of research laboratories.

    Two-qubit operation is good enough to perform fundamental logical calculations. But a three-qubit system is the minimum unit for scaling up and implementing error correction.

    The process involved entangling two qubits to begin with, in what's known as a two-qubit gate – a standard building block of quantum computers. That gate was then combined with a third qubit with an impressively high fidelity of 88 percent (a measure of how reliable the system is).

    Each of the quantum silicon dots holds a single electron, with its spin-up and spin-down states doing the encoding. The setup also included an integrated magnet, enabling each qubit to be controlled separately using a magnetic field.

    The researchers think there's plenty more to come from quantum silicon dots linking together more and more qubits in the same circuit. Full-scale quantum computers could be closer than we think.

    https://www.nature.com/articles/s41565-021-00925-0

    https://www.sciencealert.com/scientists-have-entangled-three-qubits...

  • Dr. Krishna Kumari Challa

    Why Nearly 80 Percent of Autoimmune Sufferers Are Female

    The effects of sex hormones, X chromosomes and different gut microbes may be parts of the answer.

  • Dr. Krishna Kumari Challa

    Burning space mystery solved as researchers confirm origins of 'empty sky' gamma-rays

    Star-forming galaxies are responsible for creating gamma-rays that until now had not been associated with a known origin, researchers have confirmed.

    Until now it has been unclear what created gamma-rays—one of the most energetic forms of light in the Universe—that appear in patches of seemingly "empty sky."

    The discovery could offer clues to help astronomers solve other mysteries of the Universe, such as what kind of particles make up Dark Matter—one of the holy grails of astrophysics.

    "It's a significant milestone to finally discover the origins of this gamma-ray emission, solving a mystery of the Universe astronomers have been trying to decipher since the 1960s.

    There are two obvious sources that produce large amounts of gamma-rays seen in the Universe. One when gas falls into the supermassive black holes which are found at the centers of all galaxies—called an active galactic nucleus (AGN)—and the other associated with star formation in the disks of galaxies.

    Researchers modeled the gamma-ray emission from all the galaxies in the Universe and compared our results with the predictions for other sources and found that it is star-forming galaxies that produce the majority of this diffuse gamma-ray radiation and not the AGN process.

    researchers were able to pinpoint what created these mysterious gamma-rays after obtaining a better understanding of how cosmic rays—particles that travel at speeds very close to the speed of light—move through the gas between the stars. Cosmic rays are important because they create large amounts of gamma-ray emission in star-forming galaxies when they collide with the interstellar gas.

    Matt A. Roth et al, The diffuse γ-ray background is dominated by star-forming galaxies, Nature (2021). DOI: 10.1038/s41586-021-03802-x Matt A. Roth et al, The diffuse γ-ray background is dominated by star-forming galaxies, Nature (2021). DOI: 10.1038/s41586-021-03802-x

    https://phys.org/news/2021-09-space-mystery-sky-gamma-rays.html?utm...

  • Dr. Krishna Kumari Challa

    Researchers infuse bacteria with silver to improve power efficiency in fuel cells

    team of engineers and chemists has taken a major step forward in the development of microbial fuel cells—a technology that utilizes natural bacteria to extract electrons from organic matter in wastewater to generate electrical currents. A study detailing the breakthrough was recently published in Science. 

    Living energy-recovery systems utilizing bacteria found in wastewater offer a one-two punch for environmental sustainability efforts. The natural populations of bacteria can help decontaminate groundwater by breaking down harmful chemical compounds. Now, research also shows a practical way to harness renewable energy from this process.

    The team focused on the bacteria genus Shewanella, which have been widely studied for their energy-generation capabilities. They can grow and thrive in all types of environments—including soil, wastewater and seawater—regardless of oxygen levels.  

    Shewanella species naturally break down organic waste matter into smaller molecules, with electrons being a byproduct of the metabolic process. When the bacteria grow as films on electrodes, some of the electrons can be captured, forming a microbial fuel cell that produces electricity. 

    However, microbial fuel cells powered by Shewanella oneidensis have previously not captured enough currents from the bacteria to make the technology practical for industrial use. Few electrons could move quickly enough to escape the bacteria's membranes and enter the electrodes to provide sufficient electrical currents and power.

    To address this issue, the researchers added nanoparticles of silver to electrodes that are composed of a type of graphene oxide. The nanoparticles release silver ions, which bacteria reduce to silver nanoparticles using electrons generated from their metabolic process and then incorporate into their cells. Once inside the bacteria, the silver particles act as microscopic transmission wires, capturing more electrons produced by the bacteria.

    With greatly improved electron transport efficiency, the resulting silver-infused Shewanella film outputs more than 80% of the metabolic electrons to external circuit, generating a power of 0.66 milliwatts per square centimeter—more than double the previous best for microbial-based fuel cells.

    Silver nanoparticles boost charge extraction efficiency in Shewanella microbial fuel cells, Science (2021). DOI: 10.1126/science.abf3427

    https://phys.org/news/2021-09-infuse-bacteria-silver-power-efficien...

  • Dr. Krishna Kumari Challa

    New technology makes it possible to see clearly through murky water

    Researchers have developed a new method that can automatically produce clear images through murky water. The new technology could be useful for searching for drowning victims, documenting submerged archaeological artifacts and monitoring underwater farms.

    Imaging clearly underwater is extremely challenging because the water and the particles in it tend to scatter light. But, because scattered light is partially polarized, imaging using a camera that is sensitive to polarization can be used to suppress scattered light in underwater images.

    A  new method overcomes the limitations of traditional polarimetric underwater imaging, laying the groundwork for taking this method out of the lab and into the field.

    Traditional approaches to underwater imaging use either prior knowledge of the imaging area or the background of an image to calculate and remove scattered light. These methods have limited utility in the field because they typically require manual processing, images do not always have visible backgrounds, and prior information is not always available.

    To overcome these challenges, the researchers combined a traditional polarized imaging setup with a new algorithm that automatically finds the optimal parameters to suppress the scattering light. This not only significantly improves image contrast to achieve clear imaging but can be used without any prior knowledge of the imaging area and for images with or without background regions.

    Hongyuan Wang et al, Automatic underwater polarization imaging without background region or any prior, Optics Express (2021). DOI: 10.1364/OE.434398

    https://phys.org/news/2021-09-technology-murky.html?utm_source=nwle...

  • Dr. Krishna Kumari Challa

    Part of the universe's missing matter found

    Galaxies can receive and exchange matter with their external environment thanks to the galactic winds created by stellar explosions. Via the MUSE instrument from the Very Large Telescope at the ESO, an international research team, led on the French side by the CNRS and l'Université Claude Bernard Lyon 1, has mapped a galactic wind for the first time. This unique observation, which is detailed in a study published in MNRAS on 16 September 2021, helped to reveal where some of the universe's missing matter is located and to observe the formation of a nebula around a galaxy.

    Galaxies are like islands of stars in the universe, and possess ordinary, or baryonic, matter, which consists of elements from the periodic table, as well as dark matter, whose composition remains unknown. One of the major problems in understanding the formation of galaxies is that approximately 80% of the baryons that make up the normal matter of galaxies is missing. According to models, they were expelled from galaxies into inter-galactic space by the galactic winds created by stellar explosions.

    An international team led on the French side by researchers from the CNRS and l'Université Claude Bernard Lyon successfully used the MUSE instrument to generate a detailed map of the galactic wind driving exchanges between a young galaxy in formation and a nebula (a cloud of gas and interstellar dust).

    The perfect positioning of the galaxy and the quasar, as well as the discovery of gas exchange due to galactic winds, made it possible to draw up a unique map. This enabled the first observation of a nebula in formation that is simultaneously emitting and absorbing magnesium—some of the universe's missing baryons—with the Gal1 galaxy.

    This type of normal matter nebula is known in the near universe, but their existence for young galaxies in formation had only been supposed.

    Scientists thus discovered some of the universe's missing baryons, thereby confirming that 80–90% of normal matter is located outside of galaxies, an observation that will help expand models for the evolution of galaxies.

     Johannes Zabl et al, MusE GAs FLOw and Wind (MEGAFLOW) VIII. Discovery of a Mgii emission halo probed by a quasar sightline, Monthly Notices of the Royal Astronomical Society (2021). DOI: 10.1093/mnras/stab2165

    https://phys.org/news/2021-09-universe.html?utm_source=nwletter&...